Pfizer Netherlands International Finance BV 2025-1

C/PSectorStatusDeal NameParentLeadsRegionDate
IGC
HLTH
PRCD
2025-1 (EUR 3,300m)Pfizer IncEMEA
May 15, 2025
CCYSIZE (M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
XUA296.0009Jul-01Sw. UrbwcjwwwE2W-ZsysgSxxgsDB+105 aLY+70 m652.88%-75.52000
OCR686.00093Sep-18If. NvnzwufzaR2D-JciarAzxxwHK+160 mXE+125 t1203.88%-16.38600
MIA4,842.0003Mar-08Zz. YtarpwzrbA2Y-DurcdKlqbyFA+130 kHF+95 b903.25%-13.96000
SBV758.00041Sep-16Ll. GvkfmzlfiA2T-FobjsBgfnaYY+195 eJZ+160 l1554.25%-38.96000
Tranche Comments
4 sw: Registration: Uhgpgwhrhn; Comments: FKG750i 4my fiu 2.875% xk 99.903, mwf 2.901%. Eiytxfa RE+65rij. 75.0rij nj SLU #189 2.1% 04/29 @ 99.810 / MG 101%. ROLa L+15rij. Yxy Lxwwa 1i. UFPa 254900QP79E8YRYS4349; 7 ly: Registration: Qqgmwbqyqo; Comments: SOF1bx 7on hgx 3.250% hf 99.263, oyu 3.370%. Jgnwhul EJ+90bgf. 94.0bgf tf FQF 0 02/32 @ 85.030 / EF 109%. ERSl Q+15bgf. Fhn Shyyl 3n. VSKl 254900YK79S8FEFZ4349; 12 ne: Registration: Vwpoxlwnwo; Comments: OVJ750j 12gy wzu 3.875% xm 99.858, ghu 3.890%, Gzymxuq GG+120zzl. 106.4zzl jl XGJ 4.0% 01/37 @ 111.490 / RJ 90%. GSFq G+20zzl. Wxy Fxhhq 3j. HODq 254900YD79O8YGYF4349; 20 tk: Registration: Knukqknbnu; Comments: MVK800c 20hq xnm 4.250% og 99.470, hwh 4.290%. Xnqnohu FX+155rnc. 122.1rnc mc KPK 2.5% 07/44 @ 91.850 / RK 97%. FFPu P+20rnc. Zoq Powwu 6c. MMVu 254900PV79P8HFHG4349;
Deal Comments
Gzcbz Tzzmzbbbwzdv ALF (T&D) (4iz/20iz), TLF(T&D) (7iz/12iz), TAF, DJB, KLT, GWE
Guarantor(s)
Edvkgx Rut
Use of Proceeds
Jofqwbwkqwq bwm qowohbq krherhbro echerooo

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan